Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient

Nephrology

Volumn 19, Issue 4, 2014, Pages 186-194

  Xue, Wei ^a   Xie, Yuanyuan ^a   Wang, Qin ^a   Xu, Weijia ^a   Mou, Shan ^a   Ni, Zhaohui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

acute kidney injury; kidney injury molecule 1; neutrophil gelatinase associated lipocalin; prognosis; receiver operating characteristic obstructive nephropathy

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE; HEMOGLOBIN; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MEMBRANE PROTEIN; ONCOPROTEIN; VIRUS RECEPTOR;

ACUTE KIDNEY FAILURE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSTRUCTIVE NEPHROPATHY; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; URINALYSIS; ACUTE KIDNEY INJURY; COMPLICATION; DISEASE COURSE; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK; STATISTICAL MODEL; TIME; URETERAL OBSTRUCTION; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIPOCALINS; LOGISTIC MODELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; RETROSPECTIVE STUDIES; ROC CURVE; TIME FACTORS; URETERAL OBSTRUCTION;

EID: 84896906437     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12173     Document Type: Article

References (31)

1. Dear JW, Yuen PST,. Setting the stage for acute-on-chronic kidney injury. Kidney Int. 2008; 74: 7-9.
2. Ponte B, Felipe C, Muriel A, etal. Long-term functional evolution after an acute kidney injury: A 10-year study. Nephrol. Dial. Transplant. 2008; 23: 3859-3866.
3. Smith JM, Stablein DM, Munoz R, etal. Contributions of the transplant registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr. Transplant. 2007; 11: 366-373.
4. Klahr S, Morrissey J,. Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal Physiol. 2002; 283: 861-875.
5. Chevalier RL, Thornhill BA, Forbes MS, etal. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr. Nephrol. 2010; 25: 687-697.
6. Ferguson MA, Vaidya VS, Waikar SS, etal. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int. 2010; 77: 708-714.
7. Makris K, Kafkas N,. Neutrophil gelatinase-associated lipocalin in acute kidney injury. Adv. Clin. Chem. 2012; 58: 141-191.
8. Ichimura T, Bonventre JV, Bailly V, etal. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 1998; 273: 4135-4142.
9. Ichimura T, Hung CC, Yang SA, etal. Kidney injury molecule-1: A tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am. J. Physiol. Renal Physiol. 2004; 286: 552-563.
10. de Geus HR, Betjes MG, Bakker J,. Biomarkers for the prediction of acute kidney injury: A narrative review on current status and future challenges. Clin. Kidney J. 2012; 5: 102-108.
11. Han WK, Waikar SS, Johnson A, etal. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008; 73: 863-869.
12. Endre ZH, Pickering JW, Walker RJ, etal. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int. 2011; 79: 1119-1130.
13. Nickolas TL, Schmidt-Ott KM, Canetta P, etal. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: A multicenter prospective cohort study. J. Am. Coll. Cardiol. 2012; 59: 246-255.
14. Mehta RL, Kellum JA, Shah SV, etal. Acute Kidney Injury Network: Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit. Care 2007; 11: R31.
15. Schortgen F, Lacherade JC, Bruneel F, etal. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet 2001; 357: 911-916.
16. Levey AS, Coresh J, Greene T, etal. Chronic Kidney Disease Epidemiology Collaboration. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin. Chem. 2007; 53: 766-772.
17. Chevalier RL,. Biomarkers of congenital obstructive nephropathy: Past, present and future. J. Urol. 2004; 172: 852-857.
18. Wasilewska A, Taranta-Janusz K, Dȩbek W, etal. KIM-1 and NGAL: New markers of obstructive nephropathy. Pediatr. Nephrol. 2011; 26: 579-586.
19. Takaharu I, Shan M,. Kidney injury molecule-1 in acute kidney injury and renal repair: a review. J Chin Integr Medi. 2008; 6: 533-538
20. Han WK, Bailly V, Abichandani R, etal. Kidney injury molecule 1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int. 2002; 62: 237-244.
21. Ichimura T, Asseldonk EJ, Humphreys BD, etal. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 2008; 118: 1657-1668.
22. Vaidya VS, Ozer JS, Dieterle F, etal. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat. Biotechnol. 2010; 28: 478-485.
23. Zhang PL, Rothblum LI, Han WK, etal. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int. 2008; 73: 608-614.
24. Soni SS, Ronco C, Katz N, etal. Early diagnosis of acute kidney injury: The promise of novel biomarkers. Blood Purif. 2009; 28: 165-174.
25. Mori K, Lee HT, Rapoport D, etal. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Invest. 2005; 115: 610-621.
26. Mishra J, Dent C, Tarabishi R, etal. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-1238.
27. Chaturvedi S, Farmer T, Kapke GF,. Assay validation for KIM-1: Human urinary renal dysfunction biomarker. Int. J. Biol. Sci. 2009; 5: 128-134.
28. van Timmeren MM, van den Heuvel MC, Bailly V, etal. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J. Pathol. 2007; 212: 209-217.
29. Peralta CA, Katz R, Bonventre JV, etal. Associations of Urinary Levels of Kidney Injury Molecule 1 (KIM-1) and Neutrophil Gelatinase-Associated Lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Am. J. Kidney Dis. 2012; 60: 904-911.
30. Haase M, Bellomo R, Devarajan P, etal. NGAL Meta-analysis Investigator Group: Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: A systematic review and meta-analysis. Am. J. Kidney Dis. 2009; 54: 1012-1024.
31. Bhavsar NA, Köttgen A, Coresh J, etal. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM-1) as Predictors of Incident CKD Stage 3: The Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Kidney Dis. 2012; 60: 233-240.